Pomdoctor Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POM research report →
Price Chart
About the company
Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications.
- CEO
- Zhenyang Shi
- IPO
- 2025
- Employees
- 165
- HQ
- Guangzhou, GD, CN
Get TickerSpark's AI analysis on POM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.55M
- P/E
- -0.17
- PEG
- 0.01
- P/S
- 0.26
- P/B
- -1.17
- EV/EBITDA
- -0.61
- Div Yield
- 0.00%
- Gross Margin
- 11.68%
- Op Margin
- -74.18%
- Net Margin
- -83.71%
- ROE
- 79.79%
- ROIC
- 3098.71%
Latest fiscal year · YoY change
- Revenue
- $399.91M+16.7%
- Gross Profit
- $52.28M+9.6%
- Op Income
- $-116,373,704
- Net Income
- $-212,579,117-48.3%
- EPS
- $-65.88+3.3%
- OCF Growth
- -820.5%
- FCF Growth
- -824.6%
- 52W High
- $102.42
- 52W Low
- $0.43
- 50D MA
- $1.20
- 200D MA
- $2.69
- Beta
- 2.28
- RSI (14)
- 47
- Avg Volume
- 2.05M
No earnings-call transcripts are available for POM yet.
- Free Float
- 2.3%
- Shares Outstanding
- 8.59M
- Float Shares
- 199.29K
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ks Management Corp | 53.50K | ▲ 53.50K |
| Ofi Advisors LLC | 50.58K | ▲ 177 |
| Lupo Securities, LLC | 24.80K | ▲ 17.70K |
| City National Bank | 24.42K | ▼ 30.70K |
| Guardian Investor Services LLC | 1.75K | ▲ 12 |
| Aris Wealth Services, Inc. | 583 | ▼ 1.50K |
| Pinnacle Summer Investments, Inc. | 336 | ▼ 2.19K |
| Boston Private Bank & Trust Co | 200 | 0 |
| Mariner Wealth Advisors-Nyc, LLC | 106 | ▲ 106 |
Held by 1 ETFs
Biggest fund positions in POM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Bao Wenqing | other | 0 |
| Mar 18, 26 | Li Daxue Donnelly | other | 0 |
| Mar 18, 26 | Jing Yuanyuan Crystal | other | 0 |
| Mar 18, 26 | Xu Li jinfuhua | other | 0 |
| Mar 18, 26 | Wei Dexiang | other | 0 |
| Mar 18, 26 | Luo Guoji | other | 0 |
| Mar 18, 26 | Shi Zhenyang | other | 0 |
| Mar 18, 26 | Shi Zhenyang | other | 0 |
| Mar 18, 26 | Shi Zhenyang | other | 0 |
| Mar 18, 26 | Shi Zhenyang | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our POM coverage
Recent articles, reports, and earnings notes.
No research on POM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate POM report →POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions
prnewswire.com · Nov 11
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
prnewswire.com · Nov 6
POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment
prnewswire.com · Nov 4
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
prnewswire.com · Nov 2
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
prnewswire.com · Oct 19
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
prnewswire.com · Oct 12
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
prnewswire.com · Oct 9
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
prnewswire.com · Sep 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.